WALGREEN COMPANY for WALGREEN COMPANY
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to pharmacy provider status. H.R. 3554 / S. 1909, issues related to direct and indirect remuneration fees in Medicare.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SAMANTHA HELTON New | — |
| ALETHIA JACKSON | — |
| EDWARD KALETA | — |
| KATIE L SMITH New | — |
Taxation/Internal Revenue Code TAX
Issues related to pharmacies and pharmacists, and Medicare reimbursement; Issues regarding Section 965 - Treatment of Deferred Foreign Income, and other tax issues. Issues related to corporate tax rate and other international tax provisions in Build Back Better Act (H.R.5376).
| Lobbyist | Covered position, as disclosed |
|---|---|
| SAMANTHA HELTON New | — |
| ALETHIA JACKSON | — |
| EDWARD KALETA | — |
| KATIE L SMITH New | — |
Consumer Issues/Safety/Products CSP
S. 936/H.R. 5502: INFORM Consumers Act; provisions related to online marketplace transparency. Issues related to organized retail crime.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SAMANTHA HELTON New | — |
| ELIZABETH HUNGER New | — |
| ALETHIA JACKSON | — |
| EDWARD KALETA | — |
| KATIE L SMITH New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.